PortfoliosLab logoPortfoliosLab logo
ROIV vs. SDGR
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

ROIV vs. SDGR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Roivant Sciences Ltd. (ROIV) and Schrodinger, Inc. (SDGR). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

ROIV vs. SDGR - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ROIV
Roivant Sciences Ltd.
27.65%83.43%5.34%40.55%-20.73%7.81%
SDGR
Schrodinger, Inc.
-36.47%-7.31%-46.12%91.55%-46.34%-35.49%

Fundamentals

Market Cap

ROIV:

$19.30T

SDGR:

$834.32M

EPS

ROIV:

-$0.00

SDGR:

-$1.41

PS Ratio

ROIV:

484.37K

SDGR:

3.26

PB Ratio

ROIV:

4.52K

SDGR:

2.29

Total Revenue (TTM)

ROIV:

$13.31M

SDGR:

$255.87M

Gross Profit (TTM)

ROIV:

$12.14M

SDGR:

$142.61M

EBITDA (TTM)

ROIV:

-$1.06B

SDGR:

-$85.73M

Returns By Period

In the year-to-date period, ROIV achieves a 27.65% return, which is significantly higher than SDGR's -36.47% return.


ROIV

1D
4.88%
1M
-4.28%
YTD
27.65%
6M
83.08%
1Y
174.53%
3Y*
55.41%
5Y*
10Y*

SDGR

1D
2.62%
1M
-5.80%
YTD
-36.47%
6M
-43.37%
1Y
-42.45%
3Y*
-24.44%
5Y*
-32.07%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ROIV vs. SDGR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ROIV
ROIV Risk / Return Rank: 9999
Overall Rank
ROIV Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
ROIV Sortino Ratio Rank: 9999
Sortino Ratio Rank
ROIV Omega Ratio Rank: 9898
Omega Ratio Rank
ROIV Calmar Ratio Rank: 9999
Calmar Ratio Rank
ROIV Martin Ratio Rank: 9999
Martin Ratio Rank

SDGR
SDGR Risk / Return Rank: 1313
Overall Rank
SDGR Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
SDGR Sortino Ratio Rank: 1212
Sortino Ratio Rank
SDGR Omega Ratio Rank: 1414
Omega Ratio Rank
SDGR Calmar Ratio Rank: 1616
Calmar Ratio Rank
SDGR Martin Ratio Rank: 1414
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ROIV vs. SDGR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Roivant Sciences Ltd. (ROIV) and Schrodinger, Inc. (SDGR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ROIVSDGRDifference

Sharpe ratio

Return per unit of total volatility

4.35

-0.71

+5.06

Sortino ratio

Return per unit of downside risk

5.79

-0.95

+6.74

Omega ratio

Gain probability vs. loss probability

1.68

0.89

+0.79

Calmar ratio

Return relative to maximum drawdown

14.88

-0.74

+15.62

Martin ratio

Return relative to average drawdown

43.77

-1.35

+45.13

ROIV vs. SDGR - Sharpe Ratio Comparison

The current ROIV Sharpe Ratio is 4.35, which is higher than the SDGR Sharpe Ratio of -0.71. The chart below compares the historical Sharpe Ratios of ROIV and SDGR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


ROIVSDGRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

4.35

-0.71

+5.06

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.51

Sharpe Ratio (All Time)

Calculated using the full available price history

0.45

-0.20

+0.65

Correlation

The correlation between ROIV and SDGR is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

ROIV vs. SDGR - Dividend Comparison

Neither ROIV nor SDGR has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ROIV vs. SDGR - Drawdown Comparison

The maximum ROIV drawdown since its inception was -79.22%, smaller than the maximum SDGR drawdown of -90.21%. Use the drawdown chart below to compare losses from any high point for ROIV and SDGR.


Loading graphics...

Drawdown Indicators


ROIVSDGRDifference

Max Drawdown

Largest peak-to-trough decline

-79.22%

-90.21%

+10.99%

Max Drawdown (1Y)

Largest decline over 1 year

-11.21%

-58.52%

+47.31%

Max Drawdown (5Y)

Largest decline over 5 years

-85.95%

Current Drawdown

Current decline from peak

-6.80%

-89.95%

+83.15%

Average Drawdown

Average peak-to-trough decline

-28.40%

-63.31%

+34.91%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.81%

31.80%

-27.99%

Volatility

ROIV vs. SDGR - Volatility Comparison

Roivant Sciences Ltd. (ROIV) and Schrodinger, Inc. (SDGR) have volatilities of 11.38% and 11.97%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


ROIVSDGRDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.38%

11.97%

-0.59%

Volatility (6M)

Calculated over the trailing 6-month period

30.62%

39.22%

-8.60%

Volatility (1Y)

Calculated over the trailing 1-year period

40.54%

59.91%

-19.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

61.16%

62.96%

-1.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

61.16%

70.30%

-9.14%

Financials

ROIV vs. SDGR - Financials Comparison

This section allows you to compare key financial metrics between Roivant Sciences Ltd. and Schrodinger, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00M40.00M60.00M80.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
2.00M
87.24M
(ROIV) Total Revenue
(SDGR) Total Revenue
Values in USD except per share items